In conclusions, we presented a large dataset of EGFR mutations in Chinese NSCLC patients including a long list of novel EGFR mutations identified, providing valuable information for the diagnosis and subsequent treatment of the disease. This evidence concerns the gene EGFR and non-small cell lung carcinoma.